Antiplatelets May Prevent Hepatic Fibrosis in Patients at Risk for Chronic Liver Disease MPR, 17 Dec 2018 Antiplatelet agents may reduce the odds of hepatic fibrosis in patients at risk for chronic liver disease, according to a meta-an…